相关实验视频
Updated: Jul 15, 2025

08:49
A 3D Organotypic Melanoma Spheroid Skin Model
Published on: May 18, 2018
15.8K
用植物化学池准黑色素瘤:跟踪马基斯特龙C
Kunal Bhattacharya1, Jubair Sikdar2, Imran Hussain2
1Pratiksha Institute of Pharmaceutical Sciences, Guwahati, Assam, 781026, India; NETES Institute of Pharmaceutical Science, Guwahati, Assam, 781125, India; Royal School of Pharmacy, The Assam Royal Global University, Assam, 781035, India.
Computers in biology and medicine
|October 1, 2023
概括
研究人员从Diplazium esculentum中发现了潜在的抗黑色素瘤化合物. 马基斯特C作为开发新型黑色素瘤治疗的主要化合物具有前景,向参与癌症进展的关键基因.
科学领域:
- 植物化学 植物化学
- 计算生物学 计算生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 黑色素瘤是一个重大的全球健康问题,每年造成许多人死亡.
- 来自自然来源的新型治疗剂的识别对于有效的黑色素瘤治疗至关重要.
研究的目的:
- 为了探索Diplazium esculentum对抗黑色素瘤活性的植物化学潜力.
- 为了识别Diplazium esculentum中向黑色素瘤相关蛋白质的生物活性分子.
主要方法:
- 利用网络药理学分析Diplazium esculentum的潜在治疗化合物.
- 进行了分子对接和动力学模拟,以评估已识别的化合物和标蛋白之间的相互作用 (MAPK1,MAPK3,AKT1).
- 进行基因丰富,生存和透分析以了解分子机制.
主要成果:
- 确定了四种关键的植物化学物质:斯蒂格马斯特-5-en-3-ol,埃斯库伦特酸,鲁丁和马基斯特龙C.
- 马基斯特龙C是基于网络药理学和分子对接的最有前途的化合物.
- 发现了14个由这些化合物调节的关键"枢纽"基因,影响黑色素瘤发展途径.
结论:
- 迪普拉齐 (Diplazium esculentum) 含有一种植物化学池,具有潜在的抗黑色素瘤作用.
- 马基斯特龙C是黑色素瘤干预的潜在化合物,需要进一步调查.
- 网络药理学和分子模拟为针对黑色素瘤的基于天然产品的药物发现提供了宝贵的见解.
相关概念视频
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Skin Cancer
4.2K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.2K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Drugs that Stabilize Microtubules
2.1K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K

